Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

January 2012 - FRMC

Effects of Norovirus VLP Vaccine
01/25/2012

Kevin L. Carter

Kevin L. Carter
Although noroviruses are a leading cause of epidemic acute gastroenteritis and sporadic cases of acute gastroenteritis, a reliable vaccine for these types of viruses has not yet been developed, nor has any specific therapy been developed to...
Although noroviruses are a leading cause of epidemic acute gastroenteritis and sporadic cases of acute gastroenteritis, a reliable vaccine for these types of viruses has not yet been developed, nor has any specific therapy been developed to...
Although noroviruses are a...
01/25/2012
First Report Managed Care
Measuring Longitudinal Change of Biomarkers in Cognitive Decline
01/25/2012

Kevin L. Carter

Kevin L. Carter
Researchers have known that using biomarkers to facilitate early detection of Alzheimer disease (AD) is crucial for developing potential treatment. Studies have shown that Aβ42 and tau protein levels in cerebrospinal fluid (CSF),...
Researchers have known that using biomarkers to facilitate early detection of Alzheimer disease (AD) is crucial for developing potential treatment. Studies have shown that Aβ42 and tau protein levels in cerebrospinal fluid (CSF),...
Researchers have known that...
01/25/2012
First Report Managed Care
Costs and Complications Associated with Tubal Ligation
01/25/2012

Tim Casey

Tim Casey
Madrid—A database analysis of women <50 years of age who received a tubal ligation and had continuous insurance coverage for 1 year after the procedure found that a substantial number of patients experienced complications, which were...
Madrid—A database analysis of women <50 years of age who received a tubal ligation and had continuous insurance coverage for 1 year after the procedure found that a substantial number of patients experienced complications, which were...
Madrid—A database analysis of...
01/25/2012
First Report Managed Care
Free Heart Medications Improve Post-MI Outcomes and Drug Adherence
01/25/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Orlando—Enhanced prescription coverage improved medication adherence and rates of first major vascular events and decreased patient spending without increasing overall health costs when eliminating medication copays for patients following...
Orlando—Enhanced prescription coverage improved medication adherence and rates of first major vascular events and decreased patient spending without increasing overall health costs when eliminating medication copays for patients following...
Orlando—Enhanced prescription...
01/25/2012
First Report Managed Care
Apixaban Not Superior to Enoxaparin for Clot Prevention in Medically Ill Patients
01/25/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Orlando—The ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial found that treatment with 30 days of oral apixaban is no more effective than 1 to 2 weeks of injected enoxaparin for preventing venous thromboembolism (VTE) in...
Orlando—The ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial found that treatment with 30 days of oral apixaban is no more effective than 1 to 2 weeks of injected enoxaparin for preventing venous thromboembolism (VTE) in...
Orlando—The ADOPT (Apixaban...
01/25/2012
First Report Managed Care
AMR101’s Effect on Lipoprotein Concentration and Size
01/25/2012

Tim Casey

Tim Casey
Orlando—A follow-up analysis of a phase 3 trial found that patients with very high triglyceride levels who took 4 g/day of AMR101 had a significant reduction in the lipoprotein concentrations of the large very-low-density lipoprotein (VLDL),...
Orlando—A follow-up analysis of a phase 3 trial found that patients with very high triglyceride levels who took 4 g/day of AMR101 had a significant reduction in the lipoprotein concentrations of the large very-low-density lipoprotein (VLDL),...
Orlando—A follow-up analysis of...
01/25/2012
First Report Managed Care

Department

News Connection
Antibacterial Drugs and MRSA in Children
01/25/2012

Kevin L. Carter

Kevin L. Carter
Although methicillin resistance is common in Staphylococcus aureus in hospitals, the presence of such resistance in the community is also increasingly reported. It is commonly referred to as community-associated methicillin-resistant...
Although methicillin resistance is common in Staphylococcus aureus in hospitals, the presence of such resistance in the community is also increasingly reported. It is commonly referred to as community-associated methicillin-resistant...
Although methicillin resistance...
01/25/2012
First Report Managed Care
News Connection
Family History Influences AD Biomarker Abnormalities
01/25/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
A family history (FH) of Alzheimer’s disease (AD) is linked to preclinical abnormalities in disease biomarkers, independent of the risk conferred by the apolipoprotein E (APOE) susceptibility gene in cognitively normal middle- to older-aged...
A family history (FH) of Alzheimer’s disease (AD) is linked to preclinical abnormalities in disease biomarkers, independent of the risk conferred by the apolipoprotein E (APOE) susceptibility gene in cognitively normal middle- to older-aged...
A family history (FH) of...
01/25/2012
First Report Managed Care
Conference Insider
Rivaroxaban Reduces Death Rates in ACS Patients
01/25/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Orlando—The anticlotting drug rivaroxaban added to standard medical treatment lowered the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in acute coronary syndrome (ACS) patients, but was associated with an increase...
Orlando—The anticlotting drug rivaroxaban added to standard medical treatment lowered the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in acute coronary syndrome (ACS) patients, but was associated with an increase...
Orlando—The anticlotting drug...
01/25/2012
First Report Managed Care

News

News
First-Year Cost of Administering and Monitoring Therapies for Multiple Sclerosis
01/25/2012

Tim Casey

Tim Casey
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an...
01/25/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Payers Spend Less For Chemotherapy in Physician Offices VS Hospitals
02/28/2018
A recent study found that chemotherapy costs were lower when the treatments were administered at physician’s offices compared to hospital outpatient facilities.
A recent study found that chemotherapy costs were lower when the treatments were administered at physician’s offices compared to hospital outpatient facilities.
A recent study found that...
02/28/2018
First Report Managed Care
News
Medicare physician pay cut reversal in Senate`s hands
06/07/2010
06/07/2010
First Report Managed Care
Choosing Therapy for Type 2 Diabetes Based on Patient-Related Variables
06/10/2015

Mary Beth Nierengarten

Mary Beth Nierengarten
With the expanding availability of multiple drugs to treat patients with type 2 diabetes, treatment can now be better tailored to the needs of each patient.
With the expanding availability of multiple drugs to treat patients with type 2 diabetes, treatment can now be better tailored to the needs of each patient.
With the expanding availability...
06/10/2015
First Report Managed Care
News
Health Insurers Seek Delay Of New Consumer-Friendly Coverage Forms
08/23/2011
08/23/2011
First Report Managed Care
News
Adjuvant Therapy Tied to Better Survival in High-Risk Merkel Cell Carcinoma
12/11/2014
Adjuvant chemoradiotherapy is associated with improved survival in patients with high-risk Merkel cell carcinoma of the head and neck.
Adjuvant chemoradiotherapy is associated with improved survival in patients with high-risk Merkel cell carcinoma of the head and neck.
Adjuvant chemoradiotherapy is...
12/11/2014
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

January 2012 Volume 9 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement